MYC is a transcription factor that is commonly overexpressed in cancer, but its key oncogenic transcriptional targets have remained elusive. Two new studies manipulated MYC expression levels in normal mouse cells and human cancer cells and analysed the effects on MYC occupancy and gene expression genome-wide. In all cell types, they found that, on upregulation, MYC widely associates with the promoters of already active genes to enhance transcriptional output further, particularly through releasing paused RNA polymerase II. Thus, MYC seems to function as a global amplifier of the transcriptional output of a particular cell type.